Exciting Advancements in Prostate Cancer Therapy

This chapter highlights upcoming advancements in prostate cancer treatments that will be showcased at the ASCO event. It covers significant topics like PSA levels' prognostic value, the impact of derolutamide on quality of life, and ongoing trials investigating PARP inhibitors in early treatment stages.